Stories of New Medicines Ⅰ
2020In this book, a scientist at the forefront of new drug development will introduce you to some of the most pivotal moments in the human struggle against disease.
Medicine is an essential part of all our lives, but how do we learn about different medicines? Where do medicines come from? How do we make sure that they're safe? How do they cure us? Understanding the stories of how new medicines come into being will help us understand the health systems in our body. In this book, a scientist at the forefront of new drug development will introduce you to some of the most pivotal moments in the human struggle against disease. With his extraordinary academic ability, scientific spirit and rich work experience, he describes in detail the untold stories behind the research and development of new medicines from the perspective of both researchers and patients.
From the well-known anti-hypertensive drugs to the much-discussed cervical cancer vaccine, from the once extremely expensive hepatitis B vaccine to anti-cancer medicines with the potential to many different types of cancers, the history of new drug research and development is also the history of the human struggle against disease. This book uses science and logic to reproduce the "black swan" and "grey rhino" during the process of drug research and development.
As a medical book written for the public, it combines the latest data with real-life stories, making it a professional yet fascinating exploration. Advanced medical knowledge has been made simple, and the touching human stories feel more real than ever.
This book depicts the history of medical development, helping us perceive diseases more reasonably. If we can better understand them, we will fear them less.
Author: Liang Guibai completed his undergraduate studies at Fudan University and earned his doctoral degree at the University of Wisconsin-Madison in the late 1980s. Doctor Liang has worked at Merck Frosst Centre for Therapeutic Research for many years and made significant contributions to the development of sitagliptin. In addition to promoting China's medical and health industry, he has also been devoted to enhancing communication and cooperation in medical industry between China and the United States.
Publisher: Yilin Press
Publication Date: July 2019